Didanosine and coarctation of the aorta Patient Reports March 11, 2010

Didanosine Side Effects Report #5373110-2
Didanosine side effect was reported by a Health Professional from UNITED STATES on June 14, 2007. Female patient, 37 years of age, was diagnosed with hiv infection , prophylaxis against hiv infection  and was treated with Didanosine. After drug was administered, patient experienced the following side effects: atrioventricular block complete, coarctation of the aorta, heat rash, live birth, metabolic acidosis, patent ductus arteriosus, ventricular septal defect. Didanosine dosage: 400 MG/DAY, UNK, ORAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.

Didanosine Side Effects Report #5426123-6
Didanosine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2007. Female patient, 37 years of age, was diagnosed with hiv infection , prophylaxis against hiv infection  and was treated with Didanosine. After drug was administered, patient experienced the following side effects: atrioventricular block complete, cardiac failure congestive, coarctation of the aorta, heat rash, metabolic acidosis, patent ductus arteriosus, ventricular septal defect. Didanosine dosage: 400 MG/DAY, ORAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.

Didanosine Side Effects Report #5292027-5
Didanosine side effect was reported by a Health Professional from UNITED STATES on Mar 19, 2007. Female patient was diagnosed with hiv infection  and was treated with Didanosine. After drug was administered, patient experienced the following side effects: coarctation of the aorta, congenital anomaly. Didanosine dosage: 400 MG/DAY, ORAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.

Didanosine Side Effects Report #5445734-5
Didanosine side effect was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Female patient, 37 years of age, was diagnosed with hiv infection , prophylaxis against hiv infection  and was treated with Didanosine. After drug was administered, patient experienced the following side effects: atrioventricular block complete, coarctation of the aorta, heat rash, metabolic acidosis, patent ductus arteriosus, ventricular septal defect. Didanosine dosage: 400 MG/DAY, ORAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.


Didanosine Side Effects Report #5374045-1
Didanosine side effect was reported by a Health Professional from UNITED STATES on June 14, 2007. Female patient, weighting 5.73 lb, was treated with Didanosine. After drug was administered, patient experienced the following side effects: atrioventricular block complete, coarctation of the aorta, heat rash, metabolic acidosis, patent ductus arteriosus. Didanosine dosage: 400 MG/DAY, TRANSPLACENTAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.

Didanosine Side Effects Report #5426125-X
Didanosine side effect was reported by a Health Professional from UNITED STATES on Aug 16, 2007. Female patient, weighting 5.73 lb, was treated with Didanosine. After drug was administered, patient experienced the following side effects: atrioventricular block complete, cardiac failure congestive, coarctation of the aorta, congenital anomaly, heart block congenital, heat rash, metabolic acidosis, patent ductus arteriosus. Didanosine dosage: 400 MG/DAY, TRANSPLACETNAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.

Didanosine Side Effects Report #5445735-7
Didanosine side effect was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Female patient, weighting 5.73 lb, was treated with Didanosine. After drug was administered, patient experienced the following side effects: atrioventricular block complete, cardiac failure congestive, coarctation of the aorta, heat rash, metabolic acidosis, neonatal disorder, patent ductus arteriosus, ventricular septal defect. Didanosine dosage: 400 MG, TRANSPLACENTAL. During the same period patient was treated with ZIDOVUDINE, KALETRA. Patient recovered.